Transparency and Dermatologic Device Approval by the US Food and Drug Administration

JAMA Dermatology - United States
doi 10.1001/jamadermatol.2017.5757
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Inclusion of Training Patients in US Food and Drug Administration Premarket Approval Cardiovascular Device Studies

Archives of Internal Medicine
2011English

Have Thoracic Endografting Outcomes Improved Since US Food and Drug Administration Approval?

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017

JAMA network open
Medicine
2020English

An Analysis of Foot and Ankle Device Recalls by the Food and Drug Administration

Cureus
2018English

Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Medical Device Review Processes of U.S. Food and Drug Administration

Iryo To Shakai
2009English

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy